Immunotherapy

Immunotherapy

Immunotherapy

Immunotherapy

• Tumor Mutational Burden and Response Rate to PD-1 Inhibition

N Engl J Med 2017; 377:2500-2501December 21, 2017DOI: 10.1056/NEJMc1713444

http://www.nejm.org/doi/full/10.1056/NEJMc1713444?query=TOC

• Tumor Mutational Burden and Response Rate to PD-1 Inhibition

N Engl J Med 2017; 377:2500-2501December 21, 2017DOI: 10.1056/NEJMc1713444

http://www.nejm.org/doi/full/10.1056/NEJMc1713444?query=TOC

• Tumor Mutational Burden and Response Rate to PD-1 Inhibition

N Engl J Med 2017; 377:2500-2501December 21, 2017DOI: 10.1056/NEJMc1713444

http://www.nejm.org/doi/full/10.1056/NEJMc1713444?query=TOC

• Tumor Mutational Burden and Response Rate to PD-1 Inhibition

N Engl J Med 2017; 377:2500-2501December 21, 2017DOI: 10.1056/NEJMc1713444

http://www.nejm.org/doi/full/10.1056/NEJMc1713444?query=TOC

Immunotherapy

• Tumor Mutational Burden and Response Rate to PD-1 Inhibition

N Engl J Med 2017; 377:2500-2501December 21, 2017DOI: 10.1056/NEJMc1713444

http://www.nejm.org/doi/full/10.1056/NEJMc1713444?query=TOC